Metlife Inc (MET) · Nov 4, 2026 · Earnings

MetLife earnings beat consensus as adjusted EPS hits record

Beat — Adjusted EPS $2.78 vs ~$2.77 consensus

MetLife earnings slightly beat consensus, with record adjusted EPS and revenue growth across its insurance and asset-management businesses, though RIS and Latin America were uneven.

MetLife is in year two of its five-year New Frontier strategy, centered on group benefits, retirement solutions, asset management and higher-growth international markets; the strategy targets double-digit adjusted EPS growth and 15–17% adjusted ROE over 2025–2029.

The quarter modestly beat the market’s bar, but this is an execution update—not a rewritten story. Adjusted EPS of $2.78 was just above the published consensus of roughly $2.77, while adjusted EPS excluding notable items reached $2.85. That is a narrow beat, not a surprise of a scale that changes how the company is viewed.

Q3 2026Q3 2025Consensus
Adjusted EPS (Earnings Release)$2.78 (+17%)$2.37~$2.77
Adjusted EPS ex. notable items (Earnings Release)$2.85 (+22%)$2.34
Adjusted PFOs ex. PRT (Third Quarter 2026 Summary)$13.525B (+8%)$12.471B
Adjusted ROE ex. notable items (Third Quarter 2026 Summary)19.6%16.7%
Direct expense ratio ex. notable items and PRT (Third Quarter 2026 Summary)11.9%11.6%

Underlying operating momentum was genuinely broad. Adjusted premiums, fees and other revenues excluding pension risk transfers rose 8%, with growth in all six segments; Group Benefits earnings increased 14% excluding notable items, Asia increased 17%, EMEA increased 30%, and MetLife Investment Management grew 9% while assets under management rose 14%. The filing says, “Revenue rose in every business segment,” and adjusted earnings were “driven by higher VII, broad-based volume growth, and favorable underwriting.”

The mix is better than the headline, but not uniformly clean. Retirement and Income Solutions reported a 6% earnings decline because of a $65 million actuarial-review charge, though earnings excluding that item rose 12% and PFOs excluding pension risk transfers jumped 33%. Latin America’s reported earnings surged 45%, but excluding notable items they rose only 3% on a reported basis and fell 5% in constant currency. Asia also saw sales decline 6% in constant currency despite stronger earnings.

Investment conditions did much of the lifting, while cost execution was less impressive. Adjusted net investment income rose 10%, with variable investment income up 49% to $720 million, and higher U.S. rates generated $551 million of after-tax derivative gains. Those gains support the quarter but are less repeatable than underwriting and fee growth. Meanwhile, the direct expense ratio worsened to 11.9% from 11.6%, even though management said it remains on track for its annual target.

Capital generation remains supportive, but the reported balance-sheet picture is mixed. MetLife repurchased $650 million of shares in the quarter and paid $380 million of common dividends, while adjusted book value per share rose 5% to $59.41. However, reported book value per share fell 22% to $30.73, reflecting market-driven accounting effects rather than a comparable deterioration in adjusted capital. The company also reaffirmed that it is on track for its free-cash-flow and expense-ratio targets rather than raising them.

Bottom line: MetLife delivered a narrow earnings beat with broad revenue growth and strong adjusted returns, reinforcing—not transforming—the New Frontier story. The main caveat is that investment income and rate-sensitive derivative gains amplified the quarter, while expense performance and a few major segments remained uneven.

What to watch next

Q3 earnings call, November 5, 2026

Original filing on SEC EDGAR

More Metlife Inc news

MetLife earnings beat consensus as adjusted EPS hits record | MET Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.